Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: A pilot study

AIDS

Volumn 24, Issue 9, 2010, Pages 1377-1380

  Gupta, Samir K ^a   Johnson, Raymond M ^a   Mather, Kieren J ^b   Clauss, Matthias ^c   Rehman, Jalees ^d   Saha, Chandan ^e   Desta, Zeruesenay ^c   Dubé, Michael P ^f  

^a West Building 430   (United States)

^b Division of Endocrinology and Metabolism   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e Division of Biostatistics   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; GAMMA INTERFERON INDUCED PROTEIN; PENTOXIFYLLINE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIRUS RNA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BRACHIAL ARTERY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY TEST; LEUKOCYTE ADHERENCE; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; LIVER DYSFUNCTION; MALE; MASS SPECTROMETRY; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADULT; ANTI-INFLAMMATORY AGENTS; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PENTOXIFYLLINE; PILOT PROJECTS; REGIONAL BLOOD FLOW; YOUNG ADULT;

EID: 77952939084     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283396024     Document Type: Article

References (13)

1. R count-guided interruption of anti-retroviral treatment. N Engl J Med 2006; 355:2283-2296.
2. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203.
3. Gupta SK, Johnson RM, Saha C, Mather KJ, Greenwald ML, Waltz JS, et al. Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate: a pilot study. AIDS 2008; 22:653-655.
4. Fossat C, Fabre D, Alimi Y, Bienvenu J, Aillaud MF, Lenoble M, et al. Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion. J Cardiovasc Pharmacol 1995; 25 (Suppl 2):S96-S100.
5. R HIV-specific cytotoxic T lymphocytes by pentoxifylline. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:417-424.
6. Dezube BJ, Lederman MM, Spritzler JG, Chapman B, Korvick JA, Flexner C, et al. High-dose pentoxifylline in patients with AIDS: inhibition of tumor necrosis factor production. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. J Infect Dis 1995; 171:1628-1632.
7. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated va-sodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-265.
8. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Noninvasive detection of endothe-lial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
9. Suessenbacher A, Frick M, Alber HF, Barbieri V, Pachinger O, Weidinger F. Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events. Vasc Med 2006; 11:239-244.
10. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40:505-510.
11. Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J, et al. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 2001; 21:1662-1667.
12. Cheng C, Tempel D, van Haperen R, de Boer HC, Segers D, Huisman M, et al. Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest 2007; 117:616-626.
13. Clauss M, Zhang Y, Rajashekhar G, Rehman J, Park I-W, He J, et al. The in vitro effects of HIV proteins, inflammatory mediators, HIV-infected T cells, and pentoxifylline on endothelial cell inflammation. 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009); 8-11 February 2009; Montreal, Canada.